AU2001295600A1 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- AU2001295600A1 AU2001295600A1 AU2001295600A AU9560001A AU2001295600A1 AU 2001295600 A1 AU2001295600 A1 AU 2001295600A1 AU 2001295600 A AU2001295600 A AU 2001295600A AU 9560001 A AU9560001 A AU 9560001A AU 2001295600 A1 AU2001295600 A1 AU 2001295600A1
- Authority
- AU
- Australia
- Prior art keywords
- novel compounds
- polypeptides
- basb201
- prophylactic
- diagnostic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 238000010188 recombinant method Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1242—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/285—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Pulmonology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention provides BASB201 polypeptides and polynucleotides encoding BASB201 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0025169.4 | 2000-10-13 | ||
| GBGB0025169.4A GB0025169D0 (en) | 2000-10-13 | 2000-10-13 | Novel compounds |
| PCT/EP2001/011561 WO2002030967A2 (en) | 2000-10-13 | 2001-10-05 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001295600A1 true AU2001295600A1 (en) | 2002-04-22 |
Family
ID=9901253
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001295600A Abandoned AU2001295600A1 (en) | 2000-10-13 | 2001-10-05 | Novel compounds |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20040047875A1 (en) |
| EP (1) | EP1326885B1 (en) |
| AT (1) | ATE515511T1 (en) |
| AU (1) | AU2001295600A1 (en) |
| CA (1) | CA2424946A1 (en) |
| ES (1) | ES2368728T3 (en) |
| GB (1) | GB0025169D0 (en) |
| WO (1) | WO2002030967A2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6993104B2 (en) * | 2001-04-27 | 2006-01-31 | Adtran, Inc. | Apparatus and method for adaptively adjusting a timing loop |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2218741A1 (en) * | 1995-04-21 | 1996-10-24 | Human Genome Sciences, Inc. | Nucleotide sequence of the haemophilus influenzae rd genome, fragments thereof, and uses thereof |
| GB9918319D0 (en) | 1999-08-03 | 1999-10-06 | Smithkline Beecham Biolog | Vaccine composition |
-
2000
- 2000-10-13 GB GBGB0025169.4A patent/GB0025169D0/en not_active Ceased
-
2001
- 2001-10-05 US US10/399,091 patent/US20040047875A1/en not_active Abandoned
- 2001-10-05 CA CA002424946A patent/CA2424946A1/en not_active Abandoned
- 2001-10-05 WO PCT/EP2001/011561 patent/WO2002030967A2/en active Application Filing
- 2001-10-05 EP EP01976281A patent/EP1326885B1/en not_active Expired - Lifetime
- 2001-10-05 AU AU2001295600A patent/AU2001295600A1/en not_active Abandoned
- 2001-10-05 ES ES01976281T patent/ES2368728T3/en not_active Expired - Lifetime
- 2001-10-05 AT AT01976281T patent/ATE515511T1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US20040047875A1 (en) | 2004-03-11 |
| ATE515511T1 (en) | 2011-07-15 |
| GB0025169D0 (en) | 2000-11-29 |
| WO2002030967A2 (en) | 2002-04-18 |
| ES2368728T3 (en) | 2011-11-21 |
| EP1326885B1 (en) | 2011-07-06 |
| WO2002030967A3 (en) | 2002-11-07 |
| EP1326885A2 (en) | 2003-07-16 |
| CA2424946A1 (en) | 2002-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO1999058562A3 (en) | Novel compounds | |
| GB9810276D0 (en) | Novel compounds | |
| GB9820003D0 (en) | Novel compounds | |
| GB9811260D0 (en) | Novel compounds | |
| AU3164600A (en) | Novel compounds | |
| GB9809683D0 (en) | Novel compounds | |
| AU4504999A (en) | Novel compounds | |
| GB9810285D0 (en) | Novel compounds | |
| GB9812440D0 (en) | Novel compounds | |
| AU4567300A (en) | Novel compounds | |
| AU2001295599A1 (en) | Basb205 polypeptides and polynucleotides coding therefor | |
| WO2000043519A3 (en) | Neisseria meningitidis polypeptides | |
| GB0025170D0 (en) | Novel compounds | |
| GB9918208D0 (en) | Novel compounds | |
| WO2002034768A3 (en) | Polypeptides and polynucleodides from haemophilus influenzae and their use | |
| AU6832300A (en) | Novel compounds | |
| AU2001295600A1 (en) | Novel compounds | |
| GB9918302D0 (en) | Novel compounds | |
| WO2002034772A3 (en) | Novel compounds | |
| WO2003010195A3 (en) | Novel compounds | |
| AU6568800A (en) | Novel compounds | |
| AU6439700A (en) | Novel compounds | |
| AU1383901A (en) | Novel compounds | |
| AU1580300A (en) | Novel compounds | |
| GB9914945D0 (en) | Novel compounds |